CDC shooter's motive revealed — documents show discontent with COVID-19 vaccines
Documents found in a search of the home where Patrick Joseph White lived with his parents 'expressed the shooter's discontent with the COVID-19 vaccinations,' Georgia Bureau of Investigation Director Chris Hosey said.
White, 30, had written about wanting to make 'the public aware of his discontent with the vaccine,' Hosey said.
Advertisement
3 Documents found in a search of the home where CDC shooter Patrick Joseph Smith lived with his parents revealed his discontent with the COVID-19 vaccinations.
AP
White also had recently verbalized thoughts of suicide, which led to law enforcement being contacted several weeks before the shooting, Hosey said. He died at the scene Friday of a self-inflicted gunshot wound after killing a police officer.
Asked about threats based on misinformation regarding the CDC and its vaccine work, FBI Special Agent Paul Brown said Tuesday: 'We've not seen an uptick, although any rhetoric that suggests or leads to violence is something we take very seriously.'
Advertisement
'Although we are tracking it, we are sensitive to it, we have not seen that uptick,' said Brown, who leads the FBI's Atlanta division.
The suspect's family was fully cooperating with the investigation, authorities said at the Tuesday news briefing. White had no known criminal history, Hosey said.
3 Patrick Joseph Smith fired more than 180 shots into the CDC campus in Atlanta and broke 150 windows on Friday.
AP
Executing a search warrant at the family's home in the Atlanta suburb of Kennesaw, authorities recovered written documents that are being analyzed, and seized electronic devices that are undergoing a forensic examination, the agency said.
Advertisement
Investigators also recovered a total of five firearms, including a gun that belonged to his father that he used in the attack, Hosey said.
Hosey said the suspect did not have a key to the gun safe: 'He broke into it,' he said.
White had been stopped by CDC security guards before driving to a pharmacy across the street, where he opened fire from a sidewalk, authorities said. The bullets pierced 'blast-resistant' windows across the campus, pinning employees down during the barrage. More than 500 shell casings have been recovered from the crime scene, the GBI said.
In the aftermath, officials at the CDC are assessing the security of the campus and making sure they notify officials of any new threats.
Advertisement
3 Police vehiles near Emory University and the CDC campus in Atlanta after the shooting on Aug. 8, 2025.
Getty Images
U.S. Health Secretary Robert F. Kennedy Jr. toured the CDC campus on Monday, accompanied by Deputy Secretary Jim O'Neill and CDC Director Susan Monarez, according to a health agency statement.
'No one should face violence while working to protect the health of others,' Kennedy said in a statement Saturday. It said top federal health officials are 'actively supporting CDC staff.'
Kennedy also visited the DeKalb County Police Department, and later met privately with the slain officer's wife.
A photo of the suspect will be released later Tuesday, Hosey said, but he encouraged the public to remember the face of the officer instead.
Kennedy was a leader in a national anti-vaccine movement before President Donald Trump selected him to oversee federal health agencies, and has made false and misleading statements about the safety and effectiveness of COVID-19 shots and other vaccines.
Some unionized CDC employees called for more protections. Some employees who recently left the agency as the Trump administration pursues widespread layoffs, meanwhile, squarely blamed Kennedy.
Years of false rhetoric about vaccines and public health was bound to 'take a toll on people's mental health,' and 'leads to violence,' said Tim Young, a CDC employee who retired in April.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
26 minutes ago
- Newsweek
Donald Trump's Move to Seize DC Metro Police Control Triggers Lawsuit
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The nation's capital filed a lawsuit Friday to block President Donald Trump's takeover of its police department, just hours after his administration escalated its intervention by appointing a federal official as the department's emergency head. District of Columbia Attorney General Brian Schwalb sought an emergency restraining order in federal court, arguing that placing a federal appointee in charge of the Metropolitan Police Department (MPD) is unlawful and threatens to "wreak operational havoc." The move followed U.S. Attorney General Pam Bondi's announcement Thursday night that Drug Enforcement Administration chief Terry Cole would assume the duties of police chief — including approval authority for all officer orders. The status of current Police Chief Pamela Smith, appointed by the mayor, was left unclear. Federal Bureau of Investigation (FBI) agents are seen in the Navy Yard neighborhood of Washington, D.C., Aug. 14, 2025. Federal Bureau of Investigation (FBI) agents are seen in the Navy Yard neighborhood of Washington, D.C., Aug. 14, 2025. Associated Press Schwalb contends the directive exceeds Trump's legal authority and would "sow chaos" within MPD. "The administration's unlawful actions are an affront to the dignity and autonomy of the 700,000 Americans who call D.C. home. This is the gravest threat to Home Rule that the District has ever faced, and we are fighting to stop it," he said. The Justice Department declined comment on the lawsuit, while the White House did not immediately respond to requests for comment. Trump's police takeover is the latest in a series of moves testing the boundaries of presidential power. He has relied on obscure laws and a declared state of emergency to bolster his tough-on-crime rhetoric and advance plans for mass deportations of undocumented immigrants. The action marks one of the most sweeping federal assertions over a local government in modern U.S. history. While Washington has experienced spikes in crime and homelessness, its homicide rate remains lower than several other major U.S. cities, contradicting the administration's portrayal of a public safety collapse. On Thursday, Schwalb warned that Bondi's directive was "unlawful" and instructed MPD officers to follow orders only from Chief Smith or other mayor-appointed officials. The city's attorney general is independently elected and serves as its top legal officer — separate from the federally appointed U.S. attorney for D.C., a role currently held by former Fox News host and judge Jeanine Pirro. Trump also appointed Bondi as U.S. attorney general. Bondi's order came after Smith told MPD officers to share certain information with immigration authorities only regarding non-custodial individuals, such as during traffic stops. The Justice Department criticized Smith's stance, saying it preserved "sanctuary policies." Bondi rescinded that policy and others that limited immigration inquiries or barred arrests based solely on federal warrants, requiring all new directives to receive Cole's approval. Mayor Muriel Bowser pushed back Thursday, writing on social media, "there is no statute that conveys the District's personnel authority to a federal official." Under the Home Rule Act of 1973, D.C. elects its own mayor and council, though the president retains more power over the city than other local governments. The law allows presidential control over the police for up to 30 days without congressional approval. Trump is the first president to invoke that power since its passage and has suggested seeking an extension. Schwalb argues the law restricts the president's role to requiring police services for federal purposes. Residents have noticed a growing federal presence in recent days. National Guard troops are posted near landmarks, and Humvees line the streets by Union Station. Volunteers have assisted in clearing homeless encampments, though destinations for displaced residents remain unclear. Homeland Security police stood outside Nationals Park during Thursday's baseball game, DEA agents patrolled The Wharf, and Secret Service officers were spotted in Foggy Bottom. Bowser, balancing tensions between the Republican White House and her Democratic constituency, was out of town Thursday but returned Friday. Trump's 30-day authority window coincides with an uptick in checkpoints and visible troop deployments. On Thursday night, officers set up a checkpoint in a busy nightlife district, prompting protests. The Pentagon said 800 National Guard members are now deployed for monument security, safety patrols, and beautification work. National Guard Major Micah Maxwell said troops will assist in traffic control, crowd management, and community patrols, and have been trained in de-escalation tactics. While Guard deployments are common during major D.C. events like July 4, the current scope and duration have drawn heightened attention. This is a breaking news story. Updates to follow. This article includes reporting by the Associated Press.
Yahoo
29 minutes ago
- Yahoo
You Can Now Give Yourself a Flu Vaccine at Home With a Nasal Spray
Courtesy of AstraZeneca For the first time, you may be able to vaccinate yourself against the flu from the comfort of your couch, no needle required. FluMist Home, a nasal spray version of the flu vaccine, launched on August 15 and is available to order at for people ages 18 to 49 to use themselves and for adults to give to kids ages 2 to 17. You might recall the name FluMist from previous seasons. It's been available and recommended by the CDC since 2003—barring a hiatus from 2016 to 2018 when a previous version was found ineffective against one flu type—but it had to be administered by a health care provider. The new at-home version received FDA approval in fall 2024 after studies conducted by the drug's maker AstraZeneca showed the general public could DIY it or supply it to a child just as well as a clinician could. This launch stands to increase the number of people who get vaccinated by lowering a couple common barriers, like the inconvenience of having to go somewhere to get it done and the fear of needles, Scott Roberts, MD, an infectious disease specialist at Yale New Haven Hospital, tells SELF. And that's especially relevant now, in the wake of last year's highly severe flu season—clocking the most hospitalizations for the virus in 15 years—and as overall flu vaccination rates still lag below pre-pandemic levels. Read on to learn all the details about FluMist Home, including who it's for, how to use it, and how it stacks up to the standard shot. How does FluMist Home protect you against the flu? Both the new at-home version of FluMist and the one available to receive from a health care provider utilize the same mechanism: a live weakened virus (whereas the shot uses an inactive version). By introducing that tempered version of the virus into your nose, you trigger your immune system to pump out antibodies—so that if you were to get exposed to the flu in the future, your body would be primed to fight it. While FluMist contains a live virus, that doesn't mean it's giving you the flu. That virus has been 'adapted to a lower temperature, so it can only survive in your nose and stimulate the immune cells there, but won't get anywhere else in your body,' Ravi Jhaveri, MD, division head of infectious disease at Northwestern University School of Medicine and a scientific consultant to AstraZeneca, tells SELF. That makes it a safe option for ramping up flu-related antibodies without actually making you sick. But like the flu shot, it does come with a few potential side effects, like a runny or stuffy nose, sore throat, and fever. (If you wind up with any of these, they'll generally subside on their own in a couple days.) As for actually getting and using FluMist Home? You can order it online by filling out a brief questionnaire, which a health care provider will review to make sure you're eligible—that generally means you fall within the designated age bracket and aren't immunocompromised. You'll also select the date when you'd like the product to be delivered, which you can schedule out for up to a couple months, and once you're approved, you'll need to pay a fee of $8.99 for shipping and processing. (Most insurance plans will cover the cost of the vaccine itself.) It'll arrive in cold packaging ready to use, though you can also refrigerate it for several weeks (through the expiration date) if you need some extra time. Giving yourself the vaccine involves following the instructions to spritz it into each nostril. And it comes with a prepaid envelope to dispose of the used dispenser when you're done. Is it better to use FluMist Home or get the flu shot? The two of these are 'functionally the same' in terms of offering flu protection, Dr. Roberts says, with a couple caveats. If you're over age 50, you should stick with the shot. And because it's a live weakened virus, FluMist is not recommended for those who are immunocompromised—that's standard protocol for most live-virus vaccines due to the concern that people in this camp won't have the typical response of someone with a robust immune system, Dr. Roberts says. The CDC also doesn't suggest it for pregnant folks or those with certain preexisting health conditions. Otherwise, the choice comes down to personal preference. Maybe you'd rather avoid needles at all costs or just find it tricky to make time for that flu-shot appointment—in these scenarios, ordering FluMist Home and inoculating yourself might be more appealing. But that also means paying a small fee and investing some effort to correctly administer it. With any at-home product, there's room for user error, Dr. Roberts points out. Again, FluMist Home has been proven easy enough for the average person to use effectively, but it's possible that if you spritz it incorrectly (say, not deep enough in your nose), it might not stimulate that full immune response. You may also miss the mark if you're dealing with a runny or stuffy nose—which is why Dr. Jhaveri recommends waiting until your nose clears up if you're going to use FluMist Home. All things considered, you might find that it's more convenient to you or offers you more peace of mind to get the traditional flu shot. Whichever route you choose, the important thing is to get vaccinated. Doing so has been shown to significantly lower your risk of catching the flu and reduce the chance that you wind up seriously ill if you do. Not to mention, it'll help protect the folks in your community who are more susceptible to the flu (hello, herd immunity). It's the reason Dr. Roberts sees FluMist as a boon for public health: An additional option for getting vaccinated means we can increase access, which creates greater protection for everyone. Related: Should You Postpone Your Flu Shot If You're Feeling Sick? Here's Why Flu Season Can Last Longer Than You Might Think 6 Flu Complications to Be Aware of If You Start Feeling Super Sick Get more of SELF's great service journalism delivered right to your inbox. Originally Appeared on Self Solve the daily Crossword
Yahoo
an hour ago
- Yahoo
Trump targets bolstering of US emergency drug reserve
US President Donald Trump has ordered the bolstering of the country's Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) with important drugs, aligning with his wider ambition to reduce reliance on imported pharmaceutical products. The executive order, signed on 13 August, will see the active pharmaceutical ingredients (API) of around 26 'critical drugs' added to the SAPIR. Trump has directed the Office of the Assistant Secretary for Preparedness and Response (ASPR) to curate the list of drugs whose APIs will be stored. The office of the ASPR is within the US Department of Health and Human Services (HHS) and is responsible for safeguarding drugs involved in the country's public health strategies. The SAPIR was established in 2020 by the Trump administration in response to the Covid-19 pandemic. The reserve is supposed to have nearly two years' worth of medicine supply for the most important treatments approved by the US Food and Drug Administration (FDA), but a lack of investment means it has been near-empty for the past few years. The White House blames the Biden administration for failing to advance domestic production or fill the SAPIR, 'despite spending billions on supply chain initiatives'. Trump has requested a shorter timeframe for how long the repository should be able to provide the 26 drugs in the event of an emergency. The ASPR is tasked with obtaining a six-month supply of the critical APIs. It also instructed to update the 2022 list of 86 essential medicines, with a six-month supply planned too. The executive order has asked the ASPR to preferentially source the API via 'domestically manufactured' means. However, the office might have its work cut out to find these providers, given how reliant the US is on importing APIs. Of the manufacturers that produce APIs used in FDA-approved products, only 11% are based in the US. Around 43% of branded pharmaceutical API come from the EU. In a statement, the White House said the move to fill the SAPIR with more drugs 'addresses supply chain vulnerabilities'. A spokesperson added: 'Restoring capacity for domestic production of essential pharmaceutical products is essential to safeguarding national health and security against global supply chain disruptions.' The SAPIR executive order is part of Trump's strategy to bolster domestic pharma manufacturing. This has mainly been mediated via tariffs and economic policies. Last week, the FDA introduced a new scheme that will streamline the introduction of new pharmaceutical manufacturing facilities in the US. The PreCheck programme, unveiled by the agency on 7 August, comprises a two-phase approach to facilitate new US drug manufacturing facilities. Big pharma has been responding to Trump's pressurised calls by outlaying significant funds to boost US manufacturing sites. Johnson & Johnson is set to invest $55bn over the next four years, including a $2bn biologics production site in North Carolina that promises to create 500 jobs. Roche outlaid a similar amount, planning $50bn worth of investment in the US, which will generate more than 1,000 jobs in new and expanded facilities. "Trump targets bolstering of US emergency drug reserve" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
